Aaron Nelson

Aaron Nelson is a seasoned professional in the biotechnology and venture capital sectors, currently serving as Managing Director at Novartis Venture Fund since April 2017, where the focus is on fostering innovation and generating superior returns. Prior experience includes serving as General Partner at dRx Capital AG from January 2015 to July 2018, targeting investments in early-stage companies at the intersection of pharmaceuticals and mobilized data. Aaron’s career at Novartis spanned six years in various roles, including Director of Strategic Projects and Senior Investigator II in Translational Sciences, where efforts concentrated on adopting new patient monitoring technologies and investigating drug toxicity mechanisms. Aaron began academic pursuits as a Post-doctoral Fellow at Karolinska Institutet, studying bacterial pathogens. Education includes an M.D. from Tufts University School of Medicine, a PhD in Cell and Molecular Biology from the University of Pennsylvania, and a B.A. in Evolutionary Biology and Neuroscience from Cornell University.